Volume 53, Issue 6, Pages (June 1998)

Slides:



Advertisements
Similar presentations
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Volume 58, Issue 6, Pages (December 2000)
Volume 65, Issue 6, Pages (June 2004)
Contribution of dietary oxalate to urinary oxalate excretion
M.S. Mozaffari, C. Patel, R. Abdelsayed, S.W. Schaffer 
Plasma sodium and hypertension
Volume 82, Issue 12, Pages (December 2012)
A trial of thyroxine in acute renal failure
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Volume 67, Issue 2, Pages (February 2005)
Dieter A. Häberle, Wolfgang Biller, Takuyuki Ise, Christian J. Metz 
Volume 65, Issue 6, Pages (June 2004)
Volume 88, Issue 2, Pages (August 2015)
Volume 70, Issue 10, Pages (November 2006)
Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure  Christos P. Carvounis, Sabeeha Nisar, Samerah Guro-Razuman 
Salt and Hypertension American Journal of Kidney Diseases
Volume 56, Issue 4, Pages (October 1999)
Volume 54, Issue 4, Pages (October 1998)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load 
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 81, Issue 3, Pages (February 2012)
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion  Lynda A. Frassetto, Eileen Nash,
Volume 71, Issue 11, Pages (June 2007)
17-β Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters  S. Riazi, C. Maric, C.A. Ecelbarger 
Volume 58, Issue 6, Pages (December 2000)
Elke Wühl, Otto Mehls, Franz Schaefer  Kidney International 
Blood pressure targets in hemodialysis patients
Volume 70, Issue 12, Pages (December 2006)
Volume 85, Issue 3, Pages (March 2014)
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression  Klaus Höcherl, Frieder Kees, Bernhard K. Krämer,
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Proteinuria and hypertensive nephrosclerosis in African Americans
Volume 74, Issue 8, Pages (October 2008)
Volume 78, Issue 11, Pages (December 2010)
Volume 63, Issue 6, Pages (June 2003)
Volume 78, Issue 5, Pages (September 2010)
The initiation and progression of sickle cell nephropathy
Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats  Quaisar Ali,
Volume 81, Issue 4, Pages (February 2012)
Circadian regulation of renal function
Nina Vasavada, Chandan Saha, Rajiv Agarwal  Kidney International 
Volume 69, Issue 5, Pages (March 2006)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE  L.F. Quintana, B. Guzmán, S. Collado,
Inhibition of pressure natriuresis in mice lacking the AT2 receptor
Volume 67, Pages S15-S19 (January 2005)
Phosphate binders on iron basis: A new perspective?
Volume 75, Issue 12, Pages (June 2009)
Contribution of dietary oxalate to urinary oxalate excretion
Salt sensitivity in genetically hypertensive rats of the Lyon strain
Is it the low-protein diet or simply the salt restriction?
Volume 57, Issue 3, Pages (March 2000)
A trial of thyroxine in acute renal failure
Volume 59, Issue 6, Pages (June 2001)
Volume 68, Issue 1, Pages (July 2005)
Volume 65, Issue 1, Pages (January 2004)
Renal blood flow in experimental septic acute renal failure
Volume 62, Issue 5, (November 2002)
Volume 58, Issue 2, Pages (August 2000)
Volume 61, Issue 1, Pages (January 2002)
Volume 53, Issue 5, Pages (May 1998)
Longitudinal relationships between diet-dependent renal acid load and blood pressure development in healthy children  Danika Krupp, Lijie Shi, Thomas.
Volume 67, Issue 2, Pages (February 2005)
Volume 62, Issue 6, Pages (December 2002)
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Volume 71, Issue 3, Pages (February 2007)
Presentation transcript:

Volume 53, Issue 6, Pages 1471-1478 (June 1998) α-Adducin polymorphisms and renal sodium handling in essential hypertensive patients  Paolo Manunta, Daniele Cusi, Cristina Barlassina, Marco Righetti, Chiara Lanzani, Marco D’Amico, Laura Buzzi, Lorena Citterio, Paola Stella, Rodolfo Rivera, Giuseppe Bianchi  Kidney International  Volume 53, Issue 6, Pages 1471-1478 (June 1998) DOI: 10.1046/j.1523-1755.1998.00931.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Study protocol, where hypertensive patients were admitted to the hospital for six days. Urine and blood samples were collected on day 1, during controlled diet, on day 3, during hospital diet, on day 4, after furosemide, and on day 5 during the Na load. The furosemide test and Na load test were performed on days 3 and 5, as detailed in the Methods section. Kidney International 1998 53, 1471-1478DOI: (10.1046/j.1523-1755.1998.00931.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Urinary sodium (A) and potassium (B) excretion during the six day hospitalization in the two groups of patients divided according to the α adducin genotype (G/G, N = 80, □; G/W-WW, N = 28, ▪). In both groups the UNaV was similar. However, UKV was significantly higher (*P < 0.01) in the G/W-W/W patients on day 4 after the furosemide test. Data are expressed as mean± SEM. Kidney International 1998 53, 1471-1478DOI: (10.1046/j.1523-1755.1998.00931.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Renal pressure-natriuresis relantionships during furosemide administration in 28 G/W-W/W (•) and 80 G/G (○) hypertensive patients. Urinary sodium excretion rate (UNaV) was plotted on the ordinate as a function of systemic mean arterial pressure (MAP) on the abscissa. The reciprocal of the slope in G/W-W/W hypertensives was significantly different (P < 0.03) from that of G/G hypertensive patients. Kidney International 1998 53, 1471-1478DOI: (10.1046/j.1523-1755.1998.00931.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 The pressure-natriuresis relationship in hypertensive patients divided according to the α adducin genotype during an acute Na load. The pressure natriuresis relationship was obtained, as indicated in the Methods section, by plotting urinary Na excretion (UNaV) on the ordinate as a function of MAP in the abscissa. The reciprocal of the slope in 28 G/W-W/W (• patients was significantly (P < 0.001) decreased than that of 80 G/G (○) hypertensive patients. Kidney International 1998 53, 1471-1478DOI: (10.1046/j.1523-1755.1998.00931.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Relationship between changes in mean arterial pressure (MAP) and changes in body sodium from baseline during Na depletion or load in 28 G/W-W/W (•) and 80 G/G (○) hypertensive patients. Body sodium was calculated either by subtracting the sodium excretion from the sodium load or simply by subtracting the amount of sodium excretion after furosemide. The changes in MAP were calculated from the baseline of each test. The slopes of the two curves were significantly different in the two groups (P = 0.0001). Kidney International 1998 53, 1471-1478DOI: (10.1046/j.1523-1755.1998.00931.x) Copyright © 1998 International Society of Nephrology Terms and Conditions